Seller record · telehealth service · ivimhealth.com
Ivim Health
A telehealth service selling compounded GLP-1 drugs on fixed multi-month plans. An FDA warning letter names the operating entity at the address its terms print.
Passes 6 of 8 criteria. Recorded against Standard v1.1, August 2026.
Operating entity Ivim Services LLC
Dispositions at a glance
| Code | Criterion | Disposition |
|---|---|---|
| S1 | Prescriber requirement | PASS |
| S2 | Prescription gating | PASS |
| S3 | Pharmacy identification | FAIL |
| S4 | Compounding disclosure | PASS |
| S5 | Analytical documentation | FAIL |
| S6 | Business address | PASS |
| S7 | Price disclosure | PASS |
| S8 | Enforcement status | PASS |
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
S1PASSDr. Jessica Duncan, MD, DABOM is named as chief medical officer, and six affiliated telehealth practices are named in the privacy notice.Source: ivimhealth.com/about-us, ivimhealth.com/hipaa-notice · read August 2026.
S2PASSThe order path was walked from the home page and stopped at the first intake question, which asks where the buyer is in their health journey.Source: portal.ivimhealth.com/form · read August 2026.
S3FAILIvim states it selects FDA-inspected, state-regulated compounding pharmacies, and it names no facility on any page read.Source: ivimhealth.com/compounded-semaglutide · read August 2026.
S4PASSCompounded medications are not FDA-approved and do not undergo the same rigorous testing, printed on the compounded semaglutide page.Source: ivimhealth.com/compounded-semaglutide · read August 2026.
S5FAILNo certificate, lot report or test document appears on the safety pages, the pricing page, or among the 466 addresses the sitemap index lists.Source: ivimhealth.com/sitemap_index.xml · read August 2026.
S6PASSIvim Services LLC at 4200 Regent Street, Suite 200, Columbus, OH 43219 in the terms, which also give a registered office in Flint, Michigan.Source: ivimhealth.com/terms-and-conditions · read August 2026.
S7PASSCompounded semaglutide is printed at 600 dollars for a 6-month plan and 499 dollars for a 4-month plan, with membership at 75 dollars per month afterward.Source: ivimhealth.com/glp1-pricing · read August 2026.
S8PASSFDA warning letter 721816, February 2026, names Ivim Services LLC doing business as Ivim at 4200 Regent Street, Suite 200, Columbus, Ohio, the address its own terms print. It alleges that the products pictured on the website identify Ivim on the label, suggesting Ivim is the compounder of those drugs when it is not. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.Source: fda.gov, letter 721816 · read August 2026.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, vitamin injections.
Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.